Economic Times reported on 15th March 2011 on the consensus arrived at between India and European Union:

India has sorted out most of its differences with the European Union on production of low-cost generic medicines, ahead of a crucial meeting on a proposed free-trade pact next month, a government official told ET. Civil society groups, however, warn that India should be on its guard to ensure that the intellectual property rights (IPR) regime is not changed to allow extension of patents.

The EU has been pushing India to adopt more stringent IPR standards to match the strong patent protection given by it to its industry. [...]

OUVRIR MON COMPTE CREATE MY ACCOUNT